Main variables;Main activity, secondary one or a tool necessary for production;Total
Companies that carry out R&D in Biotechnology;Total;1.078
Companies that carry out R&D in Biotechnology;Main;526
Companies that carry out R&D in Biotechnology;Secondary dwellings;173
Companies that carry out R&D in Biotechnology;Tool;379
%Companies according to biotechnology used: Genetic code;Total;35
%Companies according to biotechnology used: Genetic code;Main;45
%Companies according to biotechnology used: Genetic code;Secondary dwellings;22
%Companies according to biotechnology used: Genetic code;Tool;27
%Companies according to biotechnology used: Functional units;Total;42
%Companies according to biotechnology used: Functional units;Main;52
%Companies according to biotechnology used: Functional units;Secondary dwellings;37
%Companies according to biotechnology used: Functional units;Tool;30
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Total;27
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Main;34
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Secondary dwellings;22
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Tool;19
%Companies according to biotechnology used: Bioprocesses;Total;49
%Companies according to biotechnology used: Bioprocesses;Main;43
%Companies according to biotechnology used: Bioprocesses;Secondary dwellings;51
%Companies according to biotechnology used: Bioprocesses;Tool;56
%Companies according to biotechnology used: Sub-cellular organisms;Total;8
%Companies according to biotechnology used: Sub-cellular organisms;Main;12
%Companies according to biotechnology used: Sub-cellular organisms;Secondary dwellings;6
%Companies according to biotechnology used: Sub-cellular organisms;Tool;4
%Companies according to biotechnology used: Bio-computing;Total;22
%Companies according to biotechnology used: Bio-computing;Main;33
%Companies according to biotechnology used: Bio-computing;Secondary dwellings;17
%Companies according to biotechnology used: Bio-computing;Tool;9
%Companies according to biotechnology used: Nanobiotechnology;Total;14
%Companies according to biotechnology used: Nanobiotechnology;Main;19
%Companies according to biotechnology used: Nanobiotechnology;Secondary dwellings;15
%Companies according to biotechnology used: Nanobiotechnology;Tool;6
%Companies according to biotechnology used: Other;Total;12
%Companies according to biotechnology used: Other;Main;13
%Companies according to biotechnology used: Other;Secondary dwellings;14
%Companies according to biotechnology used: Other;Tool;10
%Company by field(s) of ultimate application of biotechnology use: Human Health;Total;48
%Company by field(s) of ultimate application of biotechnology use: Human Health;Main;68
%Company by field(s) of ultimate application of biotechnology use: Human Health;Secondary dwellings;39
%Company by field(s) of ultimate application of biotechnology use: Human Health;Tool;25
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total;20
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Main;21
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Secondary dwellings;20
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Tool;19
%Company by field(s) of ultimate application of biotechnology use: Food products;Total;33
%Company by field(s) of ultimate application of biotechnology use: Food products;Main;26
%Company by field(s) of ultimate application of biotechnology use: Food products;Secondary dwellings;30
%Company by field(s) of ultimate application of biotechnology use: Food products;Tool;44
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Total;24
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Main;22
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Secondary dwellings;28
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Tool;25
%Company by field(s) of ultimate application of biotechnology use: Environment;Total;15
%Company by field(s) of ultimate application of biotechnology use: Environment;Main;12
%Company by field(s) of ultimate application of biotechnology use: Environment;Secondary dwellings;26
%Company by field(s) of ultimate application of biotechnology use: Environment;Tool;14
%Company by field(s) of ultimate application of biotechnology use: Industry;Total;14
%Company by field(s) of ultimate application of biotechnology use: Industry;Main;14
%Company by field(s) of ultimate application of biotechnology use: Industry;Secondary dwellings;20
%Company by field(s) of ultimate application of biotechnology use: Industry;Tool;9
Personnel in R&D in biotechnology (no. of persons);Total;10.191
Personnel in R&D in biotechnology (no. of persons);Main;5.753
Personnel in R&D in biotechnology (no. of persons);Secondary dwellings;1.481
Personnel in R&D in biotechnology (no. of persons);Tool;2.956
Personnel in R&D in biotechnology (no. of persons): Researchers;Total;5.774
Personnel in R&D in biotechnology (no. of persons): Researchers;Main;3.440
Personnel in R&D in biotechnology (no. of persons): Researchers;Secondary dwellings;849
Personnel in R&D in biotechnology (no. of persons): Researchers;Tool;1.485
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total;4.417
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Main;2.314
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Secondary dwellings;632
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Tool;1.471
Personnel in R&D in biotechnology (no. of persons): women;Total;5.525
Personnel in R&D in biotechnology (no. of persons): women;Main;3.332
Personnel in R&D in biotechnology (no. of persons): women;Secondary dwellings;769
Personnel in R&D in biotechnology (no. of persons): women;Tool;1.424
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total;3.015
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Main;1.902
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Secondary dwellings;419
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Tool;694
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total;2.511
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Main;1.431
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Secondary dwellings;350
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Tool;730
Personnel in R&D in biotechnology (FTE);Total;7.191,4
Personnel in R&D in biotechnology (FTE);Main;4.611,5
Personnel in R&D in biotechnology (FTE);Secondary dwellings;889,5
Personnel in R&D in biotechnology (FTE);Tool;1.690,4
Personnel in R&D in biotechnology (FTE): Researchers;Total;4.276,6
Personnel in R&D in biotechnology (FTE): Researchers;Main;2.783,2
Personnel in R&D in biotechnology (FTE): Researchers;Secondary dwellings;566
Personnel in R&D in biotechnology (FTE): Researchers;Tool;927,5
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total;2.914,7
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Main;1.828,3
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Secondary dwellings;323,5
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Tool;763
Personnel in R&D in biotechnology (FTE): women;Total;3.985,4
Personnel in R&D in biotechnology (FTE): women;Main;2.631,7
Personnel in R&D in biotechnology (FTE): women;Secondary dwellings;473,6
Personnel in R&D in biotechnology (FTE): women;Tool;880,2
Personnel in R&D in biotechnology (FTE): (women) Researchers;Total;2.234
Personnel in R&D in biotechnology (FTE): (women) Researchers;Main;1.505,4
Personnel in R&D in biotechnology (FTE): (women) Researchers;Secondary dwellings;276,8
Personnel in R&D in biotechnology (FTE): (women) Researchers;Tool;451,8
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total;1.751,4
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Main;1.126,3
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Secondary dwellings;196,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Tool;428,4
Internal expenditure on R&D (thousands of euros);Total;578.171
Internal expenditure on R&D (thousands of euros);Main;392.202
Internal expenditure on R&D (thousands of euros);Secondary dwellings;77.155
Internal expenditure on R&D (thousands of euros);Tool;108.814
1) By nature of the expense: Current expenses;Total;517.601
1) By nature of the expense: Current expenses;Main;345.782
1) By nature of the expense: Current expenses;Secondary dwellings;70.758
1) By nature of the expense: Current expenses;Tool;101.061
1.1) Remuneration to researchers;Total;213.755
1.1) Remuneration to researchers;Main;144.473
1.1) Remuneration to researchers;Secondary dwellings;30.720
1.1) Remuneration to researchers;Tool;38.563
1.2) Remuneration to technicians and assistants;Total;98.440
1.2) Remuneration to technicians and assistants;Main;61.637
1.2) Remuneration to technicians and assistants;Secondary dwellings;11.993
1.2) Remuneration to technicians and assistants;Tool;24.810
1.3) Other current expenses;Total;205.406
1.3) Other current expenses;Main;139.672
1.3) Other current expenses;Secondary dwellings;28.045
1.3) Other current expenses;Tool;37.689
2) By nature of the expense: Capital expenses;Total;60.570
2) By nature of the expense: Capital expenses;Main;46.420
2) By nature of the expense: Capital expenses;Secondary dwellings;6.397
2) By nature of the expense: Capital expenses;Tool;7.753
2.1) Land and buildings;Total;22.609
2.1) Land and buildings;Main;21.900
2.1) Land and buildings;Secondary dwellings;79
2.1) Land and buildings;Tool;630
2.2) Equipment and instruments;Total;36.169
2.2) Equipment and instruments;Main;23.279
2.2) Equipment and instruments;Secondary dwellings;6.254
2.2) Equipment and instruments;Tool;6.636
2.3) Acquisition of specific R+D software;Total;1.793
2.3) Acquisition of specific R+D software;Main;1.242
2.3) Acquisition of specific R+D software;Secondary dwellings;63
2.3) Acquisition of specific R+D software;Tool;488
1) By origin of the funds: National funds;Total;487.615
1) By origin of the funds: National funds;Main;312.995
1) By origin of the funds: National funds;Secondary dwellings;69.889
1) By origin of the funds: National funds;Tool;104.731
1.1) Own funds;Total;330.459
1.1) Own funds;Main;205.081
1.1) Own funds;Secondary dwellings;45.123
1.1) Own funds;Tool;80.255
1.2) From companies;Total;45.462
1.2) From companies;Main;23.837
1.2) From companies;Secondary dwellings;13.797
1.2) From companies;Tool;7.827
1.3) Public Administration funds;Total;66.189
1.3) Public Administration funds;Main;40.409
1.3) Public Administration funds;Secondary dwellings;10.721
1.3) Public Administration funds;Tool;15.060
1.4) From Universities;Total;25.148
1.4) From Universities;Main;25.101
1.4) From Universities;Secondary dwellings;32
1.4) From Universities;Tool;15
1.5) From non profit private institutions;Total;20.357
1.5) From non profit private institutions;Main;18.567
1.5) From non profit private institutions;Secondary dwellings;216
1.5) From non profit private institutions;Tool;1.575
1) By origin of the funds: Foreign funds;Total;90.556
1) By origin of the funds: Foreign funds;Main;79.207
1) By origin of the funds: Foreign funds;Secondary dwellings;7.266
1) By origin of the funds: Foreign funds;Tool;4.083
2.1) From EU programmes;Total;20.932
2.1) From EU programmes;Main;15.392
2.1) From EU programmes;Secondary dwellings;3.369
2.1) From EU programmes;Tool;2.172
2.2) Other foreign funds;Total;69.624
2.2) Other foreign funds;Main;63.816
2.2) Other foreign funds;Secondary dwellings;3.897
2.2) Other foreign funds;Tool;1.911
Purchase of R&D services in biotechnology (thousands of euros);Total;166.022
Purchase of R&D services in biotechnology (thousands of euros);Main;131.839
Purchase of R&D services in biotechnology (thousands of euros);Secondary dwellings;27.652
Purchase of R&D services in biotechnology (thousands of euros);Tool;6.530
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Total;97.455
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Main;77.835
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Secondary dwellings;14.188
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Tool;5.432
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Total;68.567
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Main;54.005
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Secondary dwellings;13.464
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Tool;1.098
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Total;46
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Main;56
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Secondary dwellings;45
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Tool;33
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total;13
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Main;12
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Secondary dwellings;17
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Tool;13
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total;14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Main;14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Secondary dwellings;19
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Tool;12
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total;14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Main;14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Secondary dwellings;22
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Tool;10
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Total;17
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Main;20
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Secondary dwellings;23
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Tool;12
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Total;17
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Main;20
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Secondary dwellings;21
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Tool;11
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Total;18
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Main;18
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Secondary dwellings;23
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Tool;17
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total;35
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Main;39
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Secondary dwellings;41
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Tool;28
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Total;49
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Main;54
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Secondary dwellings;49
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Tool;41
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total;21
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Main;21
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Secondary dwellings;21
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Tool;21
% Companies that have requested biotechnology patents;Total;15
% Companies that have requested biotechnology patents;Main;24
% Companies that have requested biotechnology patents;Secondary dwellings;10
% Companies that have requested biotechnology patents;Tool;7
Number of patents requested;Total;526
Number of patents requested;Main;397
Number of patents requested;Secondary dwellings;72
Number of patents requested;Tool;57
% Companies with income of an international origin related to biotechnological activities;Total;26
% Companies with income of an international origin related to biotechnological activities;Main;35,9
% Companies with income of an international origin related to biotechnological activities;Secondary dwellings;12,8
% Companies with income of an international origin related to biotechnological activities;Tool;18,2
% Turnover representing income of an international origin related to biotechnological activities;Total;1,4
% Turnover representing income of an international origin related to biotechnological activities;Main;11,7
% Turnover representing income of an international origin related to biotechnological activities;Secondary dwellings;.
% Turnover representing income of an international origin related to biotechnological activities;Tool;0,9
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Total;63,8
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Main;66,2
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Secondary dwellings;73
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Tool;49,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Total;36,2
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Main;33,8
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Secondary dwellings;27,1
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Tool;50,3
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Total;91,6
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Main;91,3
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Secondary dwellings;64,7
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Tool;95,1
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total;0,9
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Main;0,6
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Secondary dwellings;.
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Tool;3,1
% Income of an international origin related with activities according to the classification: Operating source abroad;Total;1,9
% Income of an international origin related with activities according to the classification: Operating source abroad;Main;1,6
% Income of an international origin related with activities according to the classification: Operating source abroad;Secondary dwellings;34,9
% Income of an international origin related with activities according to the classification: Operating source abroad;Tool;1,4
% Income of an international origin related with activities according to the classification: Other;Total;5,6
% Income of an international origin related with activities according to the classification: Other;Main;6,6
% Income of an international origin related with activities according to the classification: Other;Secondary dwellings;0,4
% Income of an international origin related with activities according to the classification: Other;Tool;0,5